publié le 29 avril 2021

Directives pour les MUCITES, effets secondaires d’une thérapie anti-cancer

Exemple de directive pour le traitement des plaies

MASCC/ISOO Evidence Based clinical practice GUIDELINES for MUCOSITIS secondary to

cancer therapy 2014 – ORAL MUCOSITIS

 

 

RECOMMENDATIONS IN FAVOR OF AN INTERVENTION

 

  • (i.e., strong evidence supports effectiveness in the treatment setting listed)

3. The panel recommends that low-level laser therapy (wavelength at 650 nm, power of 40 mW,

and each square centimeter treated with the required time to a tissue energy dose of 2 J/cm2) be

used to prevent oral mucositis in patients receiving hematopoietic stem cell transplantation

conditioned with high-dose chemotherapy, with or without total body irradiation (Level of Evidence II)…

 

  • (i.e., weaker evidence supports effectiveness in the treatment setting listed)

3. The panel suggests that low-level laser therapy (wavelength around 632.8 nm) be used to prevent

oral mucositis in patients undergoing radiotherapy, without concomitant chemotherapy, for head

and neck cancer (Level of Evidence III)…


Vous avez aimé cet article ? Partagez le !

Des études qui pourraient vous intéresser

Vous avez des questions, contactez-nous !

Fusion entre K-LASER et INDIBACommuniqué de presse

INDIBA S.A et Eltech K-laser S.r.l, deux experts de l’innovation et leaders mondiaux dans leurs domaines respectifs unissent leurs forces pour un avenir commun et de nouvelles opportunités mondiales.